Zenas BioPharma (ZBIO) announced the appointment of Haley Laken, Ph.D., as Chief Scientific Officer. Prior to joining Zenas, Dr. Laken served as COO at Tabby Therapeutics, a privately held biotech company focused on B-cell engineering where she led all scientific initiatives and company operations.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ZBIO: